Characterization and Quantification of Microplastics and Nanoplastics (MNPs) in Human Blood
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Centers for Disease Control and Prevention (CDC) intends to award a sole source firm fixed price contract to Columbia University for the Characterization and Quantification of Microplastics and Nanoplastics (MNPs) in Human Blood. This presolicitation notice indicates the government's intent to negotiate with only one source, but interested parties may identify their interest and capability to respond.
Scope of Work
The selected contractor will perform laboratory analyses and collaborative research activities. Key tasks include:
- Characterizing MNPs in human blood.
- Validating extraction and measurement protocols for MNPs.
- Assessing variability in MNP detection using advanced analytical instrumentation. The work aims to integrate CDC laboratory expertise with specialized analytical capabilities to establish reliable measurement approaches and enhance the scientific understanding of MNP detection in biological matrices.
Contract & Timeline
- Type: Firm Fixed Price (Sole Source)
- Authority: FAR 12.102 and 41 U.S.C. § 1901 and 1903
- Period of Performance: September 15, 2026, through September 14, 2028
- Set-Aside: None (Sole Source)
- Response Due: June 19, 2026, by 3:00 PM ET
- Published: June 12, 2026
- Place of Performance: Atlanta, GA
Additional Notes
This notice is not a request for competitive quotations. However, all responses received by the due date will be considered by the government. The decision not to compete this proposed contract, based on responses to this notice, is solely at the government's discretion. Information received will primarily be used to determine whether to conduct a competitive procurement. Any quotation or response should be emailed to the Contract Specialist at zwh7@cdc.gov.